Iniciar sesión

6.3 : Adrenergic Receptors: ɑ Subtype

ɑ-adrenoceptors show higher affinity to Adr and NA than ISO.

They are classified into ɑ₁ and ɑ₂ subtypes based on various factors.

Upon stimulation, ɑ₁ receptors activate phospholipase C , releasing IP₃ and DAG as secondary messengers.

They are present in the postsynaptic effector organs, particularly the smooth muscles of the cardiovascular and GI systems, and are responsible for vasoconstriction, increased blood pressure, and GI muscle relaxation.

ɑ₂ receptor stimulation inhibits adenylyl cyclase, decreases cAMP production, and modulates ion channels.

They are predominantly present in autonomic nerve terminals, pancreatic beta cells, vascular smooth muscles, and platelets. They affect the release of autonomic neurotransmitters and insulin, vascular smooth muscles contraction and platelet aggregation.

ɑ₁ and ɑ₂ receptors are subdivided into three subtypes based on subtype-selective drugs. For instance, tamsulosin—used for treating prostatic hyperplasia—preferentially inhibits ɑ₁-A receptors in the prostate gland over ɑ₁-B receptors in blood vessels, so they have fewer cardiovascular side effects.

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:

Adrenaline ≥ Noradrenaline >> Isoprenaline

α-adrenoceptors are further divided into α₁ and α₂-adrenoceptors.

α₁-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate (IP₃)—diacylglycerol (DAG) pathway.

α₂-Adrenoceptors: α₂-adrenoceptors are predominantly located on the presynaptic nerve endings, which control noradrenaline release. They are also found on presynaptic parasympathetic neurons. Noradrenaline released from a presynaptic sympathetic interacting with these receptors causes inhibition of ACh release. In contrast to α₁ receptors, activation of α₂ receptors causes inhibition of adenylyl cyclase, decreased intracellular cAMP levels, and closure of ion channels.

Further subdivisions: The α₁ and α₂ receptors are further classified into α_1A, α_1B, α_1D and α_2A, α_2B, α_2C subtypes, respectively, for a better understanding of drug-receptor selectivity.

Tags

Adrenergic Receptors Adrenoceptors Catecholamine Agonists adrenoceptors adrenoceptors Phospholipase C Inositol 1 4 5 trisphosphate Diacylglycerol Presynaptic Nerve Endings Noradrenaline Release Adenylyl Cyclase CAMP Levels Drug receptor Selectivity

Del capítulo 6:

article

Now Playing

6.3 : Adrenergic Receptors: ɑ Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Vistas

article

6.1 : Neuronas Adrenúdicas: Neurotransmisión

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.3K Vistas

article

6.2 : Receptores Adrenérgicos (Adrenoceptores): Clasificación

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.1K Vistas

article

6.4 : Receptores adrenérgicos: subtipo β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Vistas

article

6.5 : Agonistas adrenérgicos: agentes de acción directa

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Vistas

article

6.6 : Agonistas adrenérgicos: agentes de acción indirecta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Vistas

article

6.7 : Agonistas adrenérgicos: agentes de acción mixta

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

634 Vistas

article

6.8 : Agonistas adrenérgicos: química y relación estructura-actividad

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.5K Vistas

article

6.9 : Agonistas adrenérgicos: clasificación terapéutica

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

665 Vistas

article

6.10 : Agonistas adrenérgicos: usos terapéuticos

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

696 Vistas

article

6.11 : Antagonistas adrenérgicos: química y clasificación de los bloqueadores de los receptores ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

772 Vistas

article

6.12 : Antagonistas Adrenérgicos: Acciones Farmacológicas de los Bloqueadores de los Receptores ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

517 Vistas

article

6.13 : Antagonistas adrenérgicos: química y clasificación de los bloqueadores de los receptores de β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

482 Vistas

article

6.14 : Antagonistas Adrenérgicos: Acciones Farmacológicas de los Bloqueadores de los Receptores β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

509 Vistas

article

6.15 : Antagonistas adrenérgicos: bloqueadores de los receptores ɑ y β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

394 Vistas

See More

Copyright © 2025 MyJoVE Corporation. Todos los derechos reservados